Vancomycin Induced Thrombocytopenia - Protracted Course in a Hemodialysis Patient

5Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Vancomycin induced thrombocytopenia (VIT) is an uncommon side effect of vancomycin which can manifest from mild petechiae to life-threatening bleed. Decreased renal clearance of vancomycin results in prolonged thrombocytopenia by antibody-mediated platelet destruction in the presence of vancomycin. Improvement in thrombocytopenia is achieved with the elimination of vancomycin. We describe a patient with end stage renal disease who experienced a protracted course of thrombocytopenia from vancomycin. We illustrate the mechanism of thrombocytopenia and the treatment modalities used by us and those described in literature. VIT is an important differential in patients with thrombocytopenia admitted to the hospital.

Cite

CITATION STYLE

APA

Ajit, N. E., Devarashetty, S. P., & Master, S. (2019). Vancomycin Induced Thrombocytopenia - Protracted Course in a Hemodialysis Patient. Case Reports in Oncology, 12(3), 749–754. https://doi.org/10.1159/000503418

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free